GoodRx Holdings Inc. (NASDAQ:GDRX) is one of the oversold stocks to buy now. On January 5, Bank of America analyst Allen Lutz ...
GoodRx's telemedicine service offers oral semaglutide for weight loss, with initial pricing of $149 for 1.5 mg and 4 mg doses ...
*The Wegovy pill is now available to eligible self-pay patients at a cash price of $149 per month for the two lowest doses (1.5mg and 4mg) through April 15, 2026, after which a $199 per month cash ...
TipRanks on MSN
GoodRx price target lowered to $2.60 from $3 at BofA
BofA analyst Allen Lutz lowered the firm’s price target on GoodRx (GDRX) to $2.60 from $3 and keeps an Underperform rating on the shares. Heading ...
Novo Nordisk has launched its first oral GLP-1 weight-loss pill in the United States, expanding beyond injectable treatments ...
Shares of the healthcare savings platform GoodRx Holdings (GDRX) traded sharply lower on Tuesday after CVS Health (NYSE:CVS) announced plans to launch a simpler, cost-based drug pricing method called ...
Community Link allows independent pharmacies to direct contract with GoodRx, manage participation in the company’s Integrated Savings Program and other benefits. Manage Participation in GoodRx’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback